BSE - Delayed Quote INR

Nippon India Pharma Dir IDCW-R (0P0001BB52.BO)

150.82 +1.62 (+1.08%)
At close: April 26 at 1:30 AM GMT+5:30

Top 10 Holdings (60.04% of Total Assets)

SymbolCompany% Assets
SUNPHARMA.NS
Sun Pharmaceutical Industries Limited 14.91%
LUPIN.BO
Lupin Limited 8.40%
CIPLA.BO
Cipla Limited 6.51%
APOLLOHOSP.NS
Apollo Hospitals Enterprise Limited 5.79%
DRREDDY.BO
Dr. Reddy's Laboratories Limited 4.75%
GLAND.NS
Gland Pharma Limited 4.40%
DIVISLAB.NS
Divi's Laboratories Limited 4.36%
ZYDUSLIFE.BO
Zydus Lifesciences Limited 4.18%
JBCHEPHARM.BO
J. B. Chemicals & Pharmaceuticals Limited 3.44%
ABBOTINDIA.BO
Abbott India Limited 3.29%

Sector Weightings

Sector0P0001BB52.BO
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Overall Portfolio Composition (%)

Cash 2.84%
Stocks 97.16%
Bonds 0.00%
Others 0.00%
Preferred 0.00%
Convertible 0.00%

Bond Ratings

US Government 0.14%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

Equity Holdings

Average 0P0001BB52.BO Category Average
Price/Earnings 0.02 --
Price/Book 0.16 --
Price/Sales 0.19 --
Price/Cashflow 0.03 --
Median Market Cap 606,197.12 --
3 Year Earnings Growth 23.14 --

Bond Holdings

Performance & Risk

YTD Return 8.50%
5y Average Return 25.79%
Rank in Category (ytd) 80
% Rank in Category (ytd) --
Beta (5Y Monthly) 0.94
Morningstar Risk Rating --

Fund Overview

Category --
Fund Family Nippon Life India Asset Management Ltd
Net Assets 1.28B
YTD Return 8.86%
Yield 6.61%
Morningstar Rating --
Inception Date Jan 01, 2013

Fund Summary

Related Tickers